Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer
Authors:
- Kingshuk ChoudhuryKCKingshuk Choudhury
- Michaela A. DinanMDMichaela A. Dinan
- Shelby D. ReedSRShelby D. Reed
- Randall P. ScheriRSRandall P. Scheri
- Dan G. BlazerDBDan G. Blazer
- Sanziana A. RomanSRSanziana A. Roman
- Julie A. SosaJSJulie A. Sosa
Top Cited Papers
- 1 August 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 262 (2) , 372-377
Abstract
To describe national practice patterns regarding utilization of minimally invasive pancreaticoduodenectomy (MIPD) and compare short-term outcomes with those following open pancreaticoduodenectomy for cancer. There is increasing interest in use of MIPD; however, published data are limited to single institutional experiences. Adult patients undergoing pancreaticoduodenectomy were identified from the National Cancer Database, 2010-2011. Descriptive statistics and multivariable modeling were employed to characterize use of MIPD (laparoscopic or robotic) and compare short-term outcomes to those following open pancreaticoduodenectomy. A total of 7061 patients underwent pancreaticoduodenectomy: 983 had MIPD and 6078 had open procedures. The use of MIPD increased by 45% (179 cases) from 2010 to 2011. The majority of hospitals (92%) performing MIPD were low volume (≤ 10 cases/2 years). Factors independently associated with undergoing MIPD included fewer comorbidities, treatment at an academic institution, and a neuroendocrine tumor diagnosis (all P < 0.01). The unadjusted 30-day mortality rate was 5.1% for MIPD versus 3.1% after open surgery. For patients with adenocarcinoma, there were no differences between MIPD and open pancreaticoduodenectomy after multivariable adjustment in number of lymph nodes removed, rate of positive surgical margins, length of stay, or readmissions. However, 30-day mortality was higher for patients undergoing MIPD versus open surgery (odds ratio = 1.87, confidence interval: 1.25-2.80, P = 0.002). While there is increasing interest in employing MIPD for adenocarcinoma, its use is associated with increased 30-day mortality. The majority of hospitals performing MIPD were low volume. These results may suggest that MIPD is a complex procedure for which comprehensive protocols outlining criteria for implementation might be warranted to optimize patient safety.Keywords
This publication has 17 references indexed in Scilit:
- Influence of Patient, Physician, and Hospital Factors on 30-Day Readmission Following Pancreatoduodenectomy in the United StatesJAMA Surgery, 2013
- Laparoscopic vs Open Pancreaticoduodenectomy: Overall Outcomes and Severity of Complications Using the Accordion Severity Grading SystemJournal of the American College of Surgeons, 2012
- A Meta-Analysis of Randomized Controlled Trials that Compared Laparoscopy-Assisted and Open Distal Gastrectomy for Early Gastric CancerJournal of Gastrointestinal Surgery, 2010
- Total Laparoscopic PancreaticoduodenectomyArchives of Surgery, 2010
- Comparing the Clinical and Economic Impact of Laparoscopic Versus Open Liver ResectionAnnals of Surgical Oncology, 2009
- Laparoscopic Pancreaticoduodenectomy: Technique and OutcomesJournal of the American College of Surgeons, 2007
- One Thousand Consecutive PancreaticoduodenectomiesAnnals of Surgery, 2006
- A Comparison of Laparoscopically Assisted and Open Colectomy for Colon CancerNew England Journal of Medicine, 2004
- Laparoscopic pylorus-preserving pancreatoduodenectomySurgical Endoscopy, 1994
- PANCREATICODUODENECTOMY FOR ISLET CARCINOMAAnnals of Surgery, 1945